ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,114.63
      -0.01%
      US Tech 100
      21,524.40
      0.41%
      Dow Jones
      44,546.08
      -0.37%
      Brent Oil
      74.39
      0.00%
      Bitcoin
      97,027.41
      -0.58%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Elite Pharmaceuticals Inc (QB) (ELTP) Quote

      Elite Pharmaceuticals Inc (QB)

      Elite Pharmaceuticals Inc (QB) (ELTP)

      USOTC
      0.53
      -0.022
      (-3.99%)
      Closed February 16 4:00PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.53
      Bid
      0.5101
      Ask
      0.549
      Volume
      5,052,323
      0.445 Day's Range 0.53
      0.1213 52 Week Range 0.7598
      Market Cap
      566.185M
      Previous Close
      0.552
      Open
      0.4501
      Last Trade
      38
      @
      0.52164
      Last Trade Time
      Financial Volume
      $ 2,458,552
      VWAP
      0.486618
      Average Volume (3m)
      1,221,825
      Shares Outstanding
      1,068,273,108
      Dividend Yield
      -
      PE Ratio
      28.19
      Earnings Per Share (EPS)
      0.02
      Revenue
      56.63M
      Net Profit
      20.11M

      About Elite Pharmaceuticals Inc (QB)

      Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma... Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.elitepharma.com
      Headquarters
      Carson City, Nevada, USA
      Founded
      -
      Elite Pharmaceuticals Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ELTP. The last closing price for Elite Pharmaceuticals (QB) was $0.55. Over the last year, Elite Pharmaceuticals (QB) shares have traded in a share price range of $ 0.1213 to $ 0.7598.

      Elite Pharmaceuticals (QB) currently has 1,068,273,108 shares outstanding. The market capitalization of Elite Pharmaceuticals (QB) is $589.69 million. Elite Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of 28.19.

      Ask ADVFN Intelligence (AI)

      ELTP Latest News

      More News

      Form 8-K - Current report
      Edgar (US Regulatory)
      February 13 2025
      ELTP (-3.99%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      February 13 2025
      ELTP (-3.99%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 26 2024
      ELTP (-3.99%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 02 2024
      ELTP (-3.99%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 18 2024
      ELTP (-3.99%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 14 2024
      ELTP (-3.99%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 14 2024
      ELTP (-3.99%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      October 28 2024
      ELTP (-3.99%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      October 23 2024
      ELTP (-3.99%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.00651.241642788920.52350.560.44511160620.53604704CS
      40.048.163265306120.490.560.4458596120.50587328CS
      12-0.0999-15.85966026350.62990.6450.44512218250.535363CS
      260.3325168.354430380.19750.75980.18224219510.47427551CS
      520.338176.0416666670.1920.75980.121315984310.40011904CS
      1560.489051194.261294260.040950.75980.02689976280.25537615CS
      2600.4395485.6353591160.09050.75980.0239720400.17953524CS

      ELTP - Frequently Asked Questions (FAQ)

      What is the current Elite Pharmaceuticals (QB) share price?
      The current share price of Elite Pharmaceuticals (QB) is $ 0.53
      How many Elite Pharmaceuticals (QB) shares are in issue?
      Elite Pharmaceuticals (QB) has 1,068,273,108 shares in issue
      What is the market cap of Elite Pharmaceuticals (QB)?
      The market capitalisation of Elite Pharmaceuticals (QB) is USD 589.69M
      What is the 1 year trading range for Elite Pharmaceuticals (QB) share price?
      Elite Pharmaceuticals (QB) has traded in the range of $ 0.1213 to $ 0.7598 during the past year
      What is the PE ratio of Elite Pharmaceuticals (QB)?
      The price to earnings ratio of Elite Pharmaceuticals (QB) is 28.19
      What is the cash to sales ratio of Elite Pharmaceuticals (QB)?
      The cash to sales ratio of Elite Pharmaceuticals (QB) is 10
      What is the reporting currency for Elite Pharmaceuticals (QB)?
      Elite Pharmaceuticals (QB) reports financial results in USD
      What is the latest annual turnover for Elite Pharmaceuticals (QB)?
      The latest annual turnover of Elite Pharmaceuticals (QB) is USD 56.63M
      What is the latest annual profit for Elite Pharmaceuticals (QB)?
      The latest annual profit of Elite Pharmaceuticals (QB) is USD 20.11M
      What is the registered address of Elite Pharmaceuticals (QB)?
      The registered address for Elite Pharmaceuticals (QB) is 321 W. WINNIE LANE, #104, CARSON CITY, NEVADA, 89703
      What is the Elite Pharmaceuticals (QB) website address?
      The website address for Elite Pharmaceuticals (QB) is www.elitepharma.com
      Which industry sector does Elite Pharmaceuticals (QB) operate in?
      Elite Pharmaceuticals (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SMKGSmart Card Marketing Systems Inc (PK)
      $ 0.0019
      (189,900.00%)
      		9.86k
      TVOGTurner Valley Oil and Gas Inc (CE)
      $ 0.0005
      (49,900.00%)
      		247.03k
      AASZDAtlantic Sapphire AS (QB)
      $ 1.09
      (15,471.43%)
      		731
      TIOGTingo Group Inc (CE)
      $ 0.015
      (14,900.00%)
      		10.34k
      FPWMCharlestowne Premium Beverages Inc (CE)
      $ 0.0001
      (9,900.00%)
      		450
      ZHCLFZenith Capital Corporation (CE)
      $ 0.0001
      (-99.90%)
      		150
      ELYSElys BMG Group Inc (CE)
      $ 0.000001
      (-99.75%)
      		327
      GRMCGoldrich Mining Company (CE)
      $ 0.000001
      (-99.67%)
      		500
      THMOThermoGenesis Holdings Inc (CE)
      $ 0.000001
      (-99.67%)
      		1.16k
      ELIQQElectriq Power Holdings Inc (CE)
      $ 0.0015
      (-99.25%)
      		100
      AFFUAffluence Corp (PK)
      $ 0.00025
      (-37.50%)
      		230.6M
      DPUIDiscount Print USA Inc (PK)
      $ 0.0002
      (0.00%)
      		188.75M
      PHILPHI Group Inc (PK)
      $ 0.0002
      (0.00%)
      		161.7M
      CBDDCBD of Denver Inc (PK)
      $ 0.0002
      (0.00%)
      		150.4M
      HMBLHUMBL Inc (PK)
      $ 0.0005
      (0.00%)
      		143.28M

      ELTP Discussion

      View Posts
      The ELTP King The ELTP King 2 seconds ago
      Kids, this is why you don't do drugs.

      You say outrageous things like this (see quote below).

      Also, the outstanding share count will be near 1.2 billion at the buyout, NOT 1 billion. Read the latest 10-Q.

      So, the buyout price would be approximately **$3.9 billion**. or $3.9 a share
      👍️0
      HGilS HGilS 8 minutes ago
      I created it again from scratch:



      ### **Given:**

      - Annual Revenue: $300 million (Vyvanse being a $4.3 B Market - very conservative)

      - Annual Earnings (EBITDA): $100 million

      - Premium: 30%

      - Revenue Multiple: Let's assume 5x (this can vary based on market conditions)

      - Earnings Multiple: Let's assume 15x (this can vary based on market conditions)


      ### **Calculation:**

      Buyout Price = ({Revenue} * {Revenue Multiple}) + (Earnings}* {Earnings Multiple}) + Premium}


      {Buyout Price} = (300 million} * 5) + (100 million* 15)


      {Buyout Price} = 1,500 million} + 1,500{ million}


      {Subtotal} = 3,000 million}


      {Premium} = 3,000 million} * 0.30 = 900 million}


      {Total Buyout Price} = 3,000 { million} + 900 { million}


      {Total Buyout Price} = 3,900 { million}


      So, the buyout price would be approximately **$3.9 billion**. or $3.9 a share
      👍️ 1
      The ELTP King The ELTP King 19 minutes ago
      Looking forward to WeeZuhl weighing in on the most recent conference call.

      We also need a "Flick the tick! Repeal the Mikah tax!" update. Is a lawyer on standby?

      Thanks.
      👍️ 2 👑 2
      The ELTP King The ELTP King 26 minutes ago
      If you're planning on buying shares you better not procrastinate.

      Nasrat could HALT the stock any day if there is major news.

      Thanks.
      👍️ 2 👑 2
      The ELTP King The ELTP King 29 minutes ago
      I'm down voting anything less than $2.00

      Thanks.
      👍️ 2 👑 2
      WhenMoon WhenMoon 38 minutes ago
      Yeah, 4$ buyout near term is unlikely as Nasrat said they would need a RS to get to Nasdaq in the near term(6 Months), which would require a 4$ pps. So he does not see this company at 4$ a share right now.
      I'm thinking $1.5-$2 would be a great outcome if buyout is this year.
      👎️ 1
      The ELTP King The ELTP King 44 minutes ago
      It all depends on when Nasrat sells the company.

      If he sells it in 2030 we could get $5.00 or more if everything goes perfectly.

      However, if he does if fact sell Elite by the end of this year what's your best case and worse case PPS?

      And obviously shareholders have to approve it. If it's too low it won't pass. Even with Nasrat's warrants he STILL owns LESS than 30%.

      Will a buyout still be great for shareholders? Absolutely. Just not $4 good.
      👍️0
      luvwetscent luvwetscent 49 minutes ago
      yep
      👍️0
      tombe tombe 1 hour ago
      Sorry Ib_. Actually it won’t let me reply through a private message. I tried. I will answer your question publicly though. Yes, I do trust Nasrat to do what is best for shareholders. I have always trusted him and understand that none of us have the information or knowledge to second guess why he does what he does! It is out of our control anyway and I try not to worry about things I can not control in my older wiser years. I am out for the day, it’s a busy one!
      👍️ 4
      jour_trader jour_trader 1 hour ago
      He really emphasized the word "yet". 
      👍️0
      jour_trader jour_trader 1 hour ago
      Because they have to. It's a significant strategic event. Nasrat alresady pre-communicated the timing for the facility. It was off by a few weeks, but still got done. No harm, no foul. 
      👍️0
      jour_trader jour_trader 1 hour ago
      There isn't one now that Nasrat confirmed what I have been mentioning time and time again regarding Vyvanse market collapsing once generics grab share. Now those calcs can be revisited. It won't get you to $4 unless obscenely far off multiples are used. Will a buyout still be great for shareholders? Absolutely. Just not $4 good.
      👍️0
      HGilS HGilS 1 hour ago
      Nasdaq2020 - we need an updated list of catalysts - we need some milestones for Buyout
      👍️0
      tombe tombe 1 hour ago
      Too bad Pharma Sleuth and Couch are not around. I remember the way Couch used to go to battle every day with the naysayers, especially Dr. Lowenstein. And of course N2k
      👍️ 2
      IB_ IB_ 1 hour ago
      I know, right !!!!!!!!!

      Wonder who it is Tommy Bee ?????????

      Kinda spooky,

      IB_🤴
      👍️0
      HGilS HGilS 1 hour ago
      ANyone has the calculation for a valuation of $4 for Buyout handy? Thanks
      👍️0
      tombe tombe 2 hours ago
      Very interesting that this handle has never once posted on the Eltp board and asks this question to who else but IB_
      👍️0
      JoshSp JoshSp 2 hours ago
      What % of shares are held by the Elite leadership group and board? (does the shareholder vote really matter if board has approved)

      .......To Every Shareholder:

      Quote from the Conference Call:
      "Board of directors approve it. It'll go to you, the stockholders. The stockholders approve a a, the purchase, the sales acquisition, then it'll go to the SEC, and that will be it."

      What would be the absolute lowest offer you as a shareholder would vote YES on ???????????
      👍️0
      mrwrn2010 mrwrn2010 2 hours ago
      I'm hoping they PR it after they file the CBE-0 he mentioned in 2-3 weeks.

      "Key points about CBE-0 filings: Meaning of "CBE": "CBE" stands for "Changes Being Effected". "0" signifies immediate implementation:The "0" indicates that the change can be implemented as soon as the FDA receives the filing. Moderate changes allowed: CBE-0 filings are typically used for relatively minor changes to a drug product, like updating labeling with new safety information or changing a manufacturing site."
      👍️ 3
      imanjen13 imanjen13 2 hours ago
      And most of all learn how to spell Kool Aid for Christs sake.
      😂 1
      imanjen13 imanjen13 2 hours ago
      NH gave us the best tipbit(sic) we have heard since August 2024. I suspect cries of gaps commonly being filled will be he heard possibly as soon as tomorrow. It will be a good time to consult AI for those who may want to wait for a pullback that may never occur.
      It would be refreshing to hear from some reputable chartists.
      👍️ 1
      sharkey1 sharkey1 2 hours ago
      WOW, thats a lot, 2mill reads, Ok everybody you know the drill.

      Behave yourselves
      Pay attention . .
      Sit up straight
      Watch your peas and Qs
      Dot those eyes cross those tees

      There will be a test come Tuesday
      🤑 1
      The ELTP King The ELTP King 2 hours ago
      Nasrat GUARANTEED we'd be on the Nasdaq by the end of 2019.

      Never sounded Imminent till this time.
      👍️ 2 👑 2
      imanjen13 imanjen13 2 hours ago
      Most read Board on IH with almost 2 million reads.
      👍️ 2
      toohot toohot 2 hours ago
      NAS---received your private reply. Always thankful for your input on my beloved ELTP.
      Long and STRONG!
      PS. keep an eye for for my other stock we have discussed. I expect it to really take off this year!



      BUY $ELTP$
      👍️0
      IB_ IB_ 2 hours ago
      I wouldn't be surprised to learn that our Lebanese Leader and his side kick CFO read this board and just giggle at the grandiose post !!!!

      LoL LoL,

      IB_🤴
      👍️ 1 💤 1 🤴 1
      littlerhody littlerhody 3 hours ago
      Patience for the ELTP gang now starts with a small "p"!!!!!
      Our leader turned the conference call on its head!!!!!
      With his enormous holdings we can rest assured that he will negotiate an awesome deal!!!
      The old guard and late comers will all make some serious cash when this deal is consummated!!!
      " Vegas Baby"
      👍️ 4
      HenryB3 HenryB3 3 hours ago
      I see some have been drinking kool aide all weekend long. The carrot and dangling is a good analogy. Keep stringing along daydreamers and fantasy land folk to the "promise land" of $4,5,6 dollar buyout rumors. All while stock is being sold by a huge holder. Now a few are waking up, just not fast enough and are at $1.50 targets. Nope. Not going to happen. But don't worry, the June Conference call will prove you right. Then? The can is always kicked more and more down the road. The clock is ticking and some want to retire or cash out at a nice golden chutes package. At the expense of kool aide drinkers! Sad but I have bridges to sell all of you. Who wants a golden gate bridge? Lets start there.
      👍️ 2 🗑️ 1 😺 1 🧻 1
      luvwetscent luvwetscent 3 hours ago
      Glad someone pointed that out..the ol" stick and carrot
      👍️ 2 ❓️ 1
      jammy32 jammy32 3 hours ago
      2017. Working on getting to the Nasdaq.

      Why do you guys still belive him. He is constantly saying soon , near future. Whatever.
      👍️ 1 👎️ 2 🗑️ 1 🤕 1 🧻 1
      NASDAQ2020 NASDAQ2020 3 hours ago
      Never sounded Imminent till this time.

      ELTP
      👍️ 3 💯 1
      NASDAQ2020 NASDAQ2020 3 hours ago
      Your the KING !
      👍️ 1 🤣 1
      sharkey1 sharkey1 4 hours ago
      Hgiils, you were so right on, I hinted at the same thing, its in the wind/air/either.
      👍️ 3
      sharkey1 sharkey1 4 hours ago
      This stock is not going down. Anybody who is short on this stock, who took out a credit card loan or borrowed money.
      must be shaken in their boots.
      👍️ 4
      sharkey1 sharkey1 4 hours ago
      Rocio, that could happen, many scenarios
      There are lots of eyes on this one, every Pharma in New Jersey knows who Elite is,
      there are lots of them,
      as soon as Nasrat puts out the press release with the details
      the phones will be ringing off the hook.

      Nasrat is in no hurry He's got lots of street cred
      will make the best deal for us.
      👍️ 4 💥 2
      The ELTP King The ELTP King 4 hours ago
      Why would Elite issue a press release with that information?

      They didn't even announce the new facility.

      My GUESS is the next press release says “Elite has hired (one of the firms Nasrat mentioned) to explore opportunities”.
      👍️ 2 👑 2 🤕 1 🤢 1
      rocioyogi rocioyogi 4 hours ago
      No, actually what would happen which I would love because we would not have to cash in and pay taxes until we’re ready if we got stock for stock if hypothetically their stock was worth $30 and Nas agreed on five dollars a share is our value than we would get one share of their $30 stock for each 6 of ours which would equal the five dollar buyout price he wants 😎
      👍️ 2 💯 3
      JamesF1 JamesF1 4 hours ago
      My GUESS is the next press release says “Elite has hired (one of the firms Nasrat mentioned) to explore opportunities”.
      🎓️ 1 👍️ 7 💯 1
      The ELTP King The ELTP King 4 hours ago
      Nasrat has said these three things on EVERY conference call going back 18 months.

      There was NOTHING special about the conference call a few days ago.

      These words were M&a, move to Nasdaq, ,amazing quota, lol
      👍️ 2 👎️ 3 👑 2 😂 3 🤣 2
      HGilS HGilS 4 hours ago
      Hi sharkey

      We, the older one on this board are having our prayers answered.

      Thursday evening after th filing, I posted to Nasdaq2020 in private some keywords I would like to hear about n the teleconference the next day.

      These words were M&a, move to Nasdaq, ,amazing quota, lol

      The next day I wrote to him: he f’in did!!! lol.

      Our patience and dd will be rewarded. Vegas now!!!
      🎓️ 1 👍️ 2 👑 1 💰️ 1 💲 1
      sharkey1 sharkey1 5 hours ago
      Hypothetical press release:

      Tuesday AM.
      Elite is in talks with XYZ company, no name yet, and they are huge with billions
      in the market cap, and there stock is worth 30 bucks a share.
      And theres a leak as to who it is.
      Elites stock will shoot up fast to meet the 30 bucks.
      👍️ 1
      sharkey1 sharkey1 5 hours ago
      Can’t sleep, waiting for the M and A news that could come Tuesday morning.
      It’s a 3 day weekend, they could be working on anything. Instead of merger Monday
      could be merger Tuesday.
      👍️ 2
      rocioyogi rocioyogi 8 hours ago
      Love it:
      is time. We believe now is the right time for merger acquisition or uplisting to NASDAQ. We have been quietly working very hard on this issue. And you should expect a PR about that sometime soon.


      So we have not offered Elite for merger acquisition yet, and therefore, nobody has come and talked to us about it.
      👍️ 3
      rocioyogi rocioyogi 8 hours ago
      Love it:
      is time. We believe now is the right time for merger acquisition or uplisting to NASDAQ. We have been quietly working very hard on this issue. And you should expect a PR about that sometime soon.


      So we have not offered Elite for merger acquisition yet, and therefore, nobody has come and talked to us about it.
      👍️ 3
      luvwetscent luvwetscent 9 hours ago
      "Can't sleep" King....so watching South Park and this ad comes on for Nutrigenix product "Total.T"...a testosterone booster...said for free sample text: Elite.......hadda laugh
      👍️0
      imanjen13 imanjen13 10 hours ago
      Correction. Naltrexone market $16M, Phentermine Capsules and Tablets $47.5 a total of $63.5M combined.

      When Mikah bought Sungen's share of the Adderall products, instead of it being sold to a different entity, it removed a possible impediment to a future sale of merger
      🎓️ 1 👍️ 4
      imanjen13 imanjen13 10 hours ago
      In answering a question about the manufacturing deal Elite had with Prasco for Adderall which will expire on March 31, 2025 and will not be renewed, Hakim mentioned the ALL of our products will be sold, except for overseas, under our OWN label later this year. Apparently Naltrexone and Phentermine Capsules and Tablets, currently, which have a combined IQVR market of $47.5M, will be re labeled and sold in house by Kirkov who will probably do a better marketing job in terms of gross sales.

      I wonder if this strategy is related to the company's intention to seek merger or acquisition partners "sometime soon". It is possible that it was Elite, not Prasco, that decided to not extend the manufacturing agreement.
      The overseas sales refers to Dexcel selling Adderall in Israel sometime during the Summer under its own label.
      👍️ 4
      jour_trader jour_trader 12 hours ago
      Yes, those are companies that have brand drugs. That's not even a close comparison.  
      👍️0
      Chasing Chasing 12 hours ago
      bs. pharmas with no revenue at all get bought all the time

      but a buyout starts with the financials of the last 6-12 months.
      👍️0
      Chasing Chasing 12 hours ago
      just confirms what we already know. pretty pathetic to create an alter.
      👍️0

      Your Recent History

      USOTC
      ELTP
      Elite Pharmaceuticals (QB)
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads